| Old Articles: <Older 45301-45310 Newer> |
|---|
 |
The Motley Fool
November 9, 2010
Anders Bylund |
By Hook or by Crook: Android Sales Impress Samsung isn't killing Apple -- but then it doesn't have to.   |
The Motley Fool
November 9, 2010
David Lee Smith |
Shell Moves to Increase Its Bet on Natural Gas Shell is selling a stake in Australia's Woodside Holdings to raise money for its gas quest. |
The Motley Fool
November 9, 2010
Rich Smith |
So Much for Ambition for hhgregg It's bad news when despite all the new revenue, the company's profit actually shrank. And unfortunately for hhgregg shareholders, that's just the kind of news we're hearing today. |
The Motley Fool
November 9, 2010
Seth Jayson |
Does priceline.com Miss the Grade? With recent TTM operating margins exceeding historical averages, priceline.com looks like it is doing fine. |
The Motley Fool
November 9, 2010 |
Natural Gas Fails To Power Clean Energy Fuels Falling margins hurt Clean Energy Fuels despite impressive revenue growth. |
The Motley Fool
November 9, 2010
Andrew Bond |
Standard Motor Products Follows the Trend Favorable trends continue to buoy the automotive aftermarket. |
The Motley Fool
November 9, 2010
Christopher Barker |
Silver Wheaton Delivers Pure Gold The darling of the silver patch comes through with golden earnings. |
The Motley Fool
November 9, 2010
Travis Hoium |
Himax Sees Big-Screen TVs Fall Flat A drop in demand for big-screen TVs has hurt Himax Technologies. |
The Motley Fool
November 9, 2010
Alyce Lomax |
Goody Two-Shoes, or a Bad Fit? If the shoe fits, should you buy the stock? Let's take a look at the recent quarterly earnings reports of several high-profile footwear companies. |
Chemistry World
November 9, 2010
Andrew Turley |
Company snapshot: Novo Nordisk As the results for the third quarter of this year roll in, one pharma major - Danish company Novo Nordisk - seems to have done better than most with its diabetes medicines. |
| <Older 45301-45310 Newer> Return to current articles. |
